Connect with us

Hi, what are you looking for?

press release

Rich Insights into the Metastatic Urothelial Carcinoma

#Rich #Insights #Metastatic #Urothelial #Carcinoma

New York, USA, Oct. 17, 2022 (GLOBE NEWSWIRE) — Rich Insights into the Metastatic Urothelial Carcinoma Clinical Trial Analysis Featuring 40+ Companies and Therapies | DelveInsight

Metastasis is the leading cause of cancer-related treatment failure and cancer-related deaths. The rising occurrence of metastatic urothelial carcinoma and increasing research and development activities are the factors driving the market for metastatic urothelial carcinoma. There are several companies developing potential therapies, including Ectin Research AG, 4D pharma plc, Lurbinectedin, and several others.

DelveInsight’s Metastatic Urothelial Carcinoma Pipeline Insight 2022 report provides comprehensive global coverage of available, marketed, and pipeline metastatic urothelial carcinoma therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the metastatic urothelial carcinoma pipeline domain.

Key Takeaways from the Metastatic Urothelial Carcinoma Pipeline Report

  • DelveInsight’s metastatic urothelial carcinoma pipeline report depicts a robust space with 35+ active players working to develop 40+ pipeline therapies for metastatic urothelial carcinoma treatment. 
  • Key metastatic urothelial carcinoma companies such as Ectin Research AG, Eli Lilly and Company, Astellas Pharma Inc, Seagen Inc., Shanghai Miracogen Inc., Advaxis, Inc., 4D pharma plc, Taiho Oncology, Shanghai Miracogen Inc., Exelixis, AstraZeneca, Incyte Corporation, IO Biotech, Jazz Pharmaceuticals, Ectin Research AB, Inovio Pharmaceuticals, Janssen Research & Development, LLC, Sumitomo Pharma Oncology, Bayer, Nurix Therapeutics, Ikena Oncology, XNK Therapeutics AB, Nektar Therapeutics, Tyra Biosciences, Inc., ALX Oncology, Scholar Rock, Inc., Jounce Therapeutics, Inc., and others are evaluating new drugs for metastatic urothelial carcinoma to improve the treatment landscape.
  • Promising metastatic urothelial…

Read on GNW: Rich Insights into the Metastatic Urothelial Carcinoma

You May Also Like

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.


State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

Health News

The cosmetic and facial plastic surgery practice is hosting a grand opening celebration and ribbon cutting for its new Chattanooga state-of-the-art location.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...